MedTrace Logo

Drug Eluting Balloon Angioplasty for Dialysis Access Treatment

NCT01174472 · Status: COMPLETED · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2012-01-23

No results posted yet for this study

Summary

The aim of the study is to compare the feasibility and the effectiveness, by means of immediate and long-term results, of drug eluting balloon (DEB) versus conventional balloon angioplasty for the treatment of failing dialysis access.

Conditions

  • Dialysis
  • Angioplasty

Interventions

DEVICE

Percutaneous Transluminal Angioplasty (PTA)

Angioplasty performed with the use of the novel paclitaxel eluting balloons

DEVICE

Percutaneous Transluminal Angioplasty (PTA)

Angioplasty performed with the use of conventional angioplasty balloons

Sponsors & Collaborators

  • University of Patras

    lead OTHER

Principal Investigators

  • Dimitrios Siablis, MD, PhD · University Hospital of Patras

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-03-31
Primary Completion
2010-12-31
Completion
2012-01-31

Countries

  • Greece

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01174472 on ClinicalTrials.gov